Mobile

A Clinical trial to compare standard of care treatment: Nab-Paclitaxel/Gemcitabine alone or in combination with ACP-196 in patients with previously untreated Metastatic Pancreatic Cancer

Update Il y a 4 ans
Reference: EUCTR2015-003428-30

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To evaluate the efficacy of ACP-196 and nab-paclitaxel/gemcitabine based on ORR in subjects with metastatic pancreatic cancer using standard response criteria

Inclusion criteria

  • Metastatic Pancreatic Cancer

Links